Diagnostic reagents and system solutions of outstanding quality!
DiaSys Diagnostic Systems is a leading specialist in development and manufacturing of diagnostic system solutions of highest quality combined with ease of use and reduced environmental burden.
Focusing on clinical chemistry and immunoturbidimetric tests DiaSys introduced more than 80 optimised reagents for routine and special diagnostics in user-friendly kits for manual or automated use. Additionally, the programme includes a broad range of appropriate calibrators and controls.
The analytical instrumentation portfolio comprises automated clinical chemistry system analyzers, semi-automated analyzers, POC instruments as well as glucose/lactate/hemoglobin analyzers. The instrument line is completed by reverse osmosis systems for purified water.
DiaSys is an ISO certified company since 1996 (valid certificates ISO 13485:2003, ISO 9001:2000), and since November 2011, have been a certified Authorized Economic Operator with AEO F certification. To date, customers and partners in more than 100 countries around the world rely on DiaSys quality.
EUROMEDLAB 2013 in Milan, May 19-23
DiaSys will be exhibiting as bronze sponsor at the EUROMEDLAB in the Milan Convention Center MiCo (booth no. 78).
DiaSys Electrolytes – The photometric alternative
DiaSys presents photometric tests for sodium, potassium and chloride applicable to any clinical chemistry analyzer. These tests are an excellent alternative to ISE for all labs with a small number of tests - no separate work station, no maintenance costs! The ready-to-use reagents show excellent performance with accurate and precise results over a wide linear range. The chloride test uses an innovative methodology avoiding toxic and harming mercury compounds used in established reagents. The liquid-stable calibrator TruCal E is suitable for all three tests.
Release of Metabolic Syndrome Site!
Holzheim, 23rd April 2013
Since the Metabolic Syndrome (MetS) is getting in focus more and more nowadays, we created a Microsite dedicated to the MetS. This Microsite provides comprehensive information on the clinical relevance, diagnostic criteria and causes of the MetS. Moreover, a special focus lies on NEFA (non-esterified fatty acids). Elevated NEFA blood levels are associated with insulin resistance, type 2 diabetes, obesity, malignant diseases and the metabolic syndrome, therefore representing an excellent candidate for the identification of patients at high risk for the MetS.
For detailed information on the Metabolic Syndrome please visit: www.metabolic-syndrome.de